- Cover story: Michael McCoy, Ann M. Thayer, and Rick Mullin write on three stories of pharmaceutical outsourcing
- Jessica Morrison on chemists and virtual reality.
- Stu Borman covers the mini drug factory from the Jamison group.
- Looks like Thermo Fisher has achieved success in its bid to buy Affymetrix.
- Britt Erickson covers Congress' look into the Syngenta/ChemChina merger.
- Will be important to see if Chinese companies are ultimately stymied in their goal to own US agrochemical firms, kind of like their attempt to purchase a piece the systemically important US pork market.
- Donna Nelson asks about ubiquitous chemistry.
- ?
Monday, April 4, 2016
This week's C&EN
A few articles from this week's issue of Chemical and Engineering News:
Subscribe to:
Post Comments (Atom)
I would be interested in why Syngenta took less money from ChemChina to merge than they would have gotten from Monsanto. Were they looking after themselves, their employees, their company, or something else (no, I don't know or am not hinting I know what that something else is)?
ReplyDelete